| Ident. | Authors (with country if any) | Title |
|---|
| 000049 (2017) |
David I. Dolling [Royaume-Uni] ; Ruth L. Goodall [Royaume-Uni] ; Michael Chirara [Zimbabwe] ; James Hakim [Zimbabwe] ; Peter Nkurunziza [Ouganda] ; Paula Munderi [Ouganda] ; David Eram [Ouganda] ; Dinah Tumukunde [Ouganda] ; Moira J. Spyer [Royaume-Uni] ; Charles F. Gilks [Australie] ; Pontiano Kaleebu [Ouganda] ; David T. Dunn [Royaume-Uni] ; Deenan Pillay [Afrique du Sud] | The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data. |
| 000057 (2017) |
Cathrine Tadyanemhandu [Zimbabwe] ; Rufaro Mukombachoto [Zimbabwe] ; Clement Nhunzvi [Zimbabwe] ; Farayi Kaseke [Zimbabwe] ; Vasco Chikwasha [Zimbabwe] ; Samson Chengetanai [Zimbabwe] ; Shamila Manie [Afrique du Sud] | The prevalence of pulmonary complications after thoracic and abdominal surgery and associated risk factors in patients admitted at a government hospital in Harare, Zimbabwe-a retrospective study |
| 000093 (2017) |
M M Sengayi [Afrique du Sud] ; D. Kielkowski ; M. Egger ; L. Dreosti ; J. Bohlius | Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study. |
| 000127 (2017) |
Dinberu Seyoum [Belgique] ; Jean-Marie Degryse [Belgique] ; Yehenew Getachew Kifle [Afrique du Sud] ; Ayele Taye [Éthiopie] ; Mulualem Tadesse [Éthiopie] ; Belay Birlie [Éthiopie] ; Akalu Banbeta [Éthiopie] ; Angel Rosas-Aguirre [Belgique] ; Luc Duchateau [Belgique] ; Niko Speybroeck [Belgique] | Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models. |
| 000135 (2017) |
Eric H. Decloedt [Afrique du Sud] ; Maia Lesosky [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; John A. Joska [Afrique du Sud] | Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial. |
| 000138 (2017) |
Jessica F. Magidson [États-Unis] ; Wylene Saal [Afrique du Sud] ; Adriaan Nel [Afrique du Sud] ; Jocelyn E. Remmert [États-Unis] ; Ashraf Kagee [Afrique du Sud] | Relationship between depressive symptoms, alcohol use, and antiretroviral therapy adherence among HIV-infected, clinic-attending patients in South Africa. |
| 000146 (2017) |
Gillian M. Hunt [Afrique du Sud] ; E Kainne Dokubo [États-Unis] ; Simbarashe Takuva [Afrique du Sud] ; Tulio De Oliveira [Afrique du Sud] ; Johanna Ledwaba [Afrique du Sud] ; Nomathemba Dube [Afrique du Sud] ; Pravi Moodley [Afrique du Sud] ; Jennifer Sabatier [États-Unis] ; Varough Deyde [Afrique du Sud] ; Lynn Morris [Afrique du Sud] ; Elliot Raizes [États-Unis] | Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa. |
| 000176 (2017) |
Rachel Arnesen [États-Unis] ; Anthony P. Moll [Afrique du Sud] ; Sheela V. Shenoi [États-Unis] | Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa. |
| 000186 (2017) |
Clement G. Adu-Gyamfi ; Tracy Snyman [Afrique du Sud] ; Christopher J. Hoffmann [États-Unis] ; Neil A. Martinson [Afrique du Sud] ; Richard E. Chaisson [États-Unis] ; Jaya A. George [Afrique du Sud] ; Melinda S. Suchard | Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients. |
| 000192 (2017) |
Kwazi C. Z. Ndlovu [Afrique du Sud] ; Wilbert Sibanda [Afrique du Sud] ; Alain Assounga [Afrique du Sud] | Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study |
| 000201 (2017) |
Kathrin Zürcher [Suisse] ; Anne Mooser [Suisse] ; Nanina Anderegg [Suisse] ; Olga Tymejczyk [États-Unis] ; Margaret J. Couvillon [Suisse] ; Denis Nash [États-Unis] ; Matthias Egger [Suisse, Afrique du Sud] | Outcomes of HIV-positive patients lost to follow-up in African treatment programmes |
| 000216 (2017) |
Supa Pengpid [Thaïlande] ; Karl Peltzer [Afrique du Sud] | Multimorbidity in Chronic Conditions: Public Primary Care Patients in Four Greater Mekong Countries. |
| 000242 (2017) |
S. Janssen [Pays-Bas] ; K. Osbak [Pays-Bas] ; R. Holman [Pays-Bas] ; S. Hermans [Pays-Bas] ; A. Moekotte [Pays-Bas] ; M. Knap [Pays-Bas] ; E. Rossatanga [Gabon] ; M. Massinga-Loembe [Gabon] ; A. Alabi [Gabon] ; A. Adegnika [Gabon] ; C. Meenken [Pays-Bas] ; M. Van Vugt [Pays-Bas] ; P G Kremsner [Gabon] ; G. Meintjes [Afrique du Sud] ; T. Van Der Poll [Pays-Bas] ; M P Grobusch [Pays-Bas] | Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study. |
| 000244 (2017) |
Greg Greene [Afrique du Sud] ; Charlotte Sriruttan ; Thuy Le ; Tom Chiller ; Nelesh P. Govender | Looking for fungi in all the right places: screening for cryptococcal disease and other AIDS-related mycoses among patients with advanced HIV disease. |
| 000266 (2017) |
Kathleen Squires [États-Unis] ; Linda-Gail Bekker [Afrique du Sud] ; Christine Katlama ; Yazdan Yazdanpanah [France] ; Yan Zhou [États-Unis] ; Anthony J. Rodgers [États-Unis] ; Mark J. Dinubile [États-Unis] ; Peter A. Sklar [États-Unis] ; Randi Y. Leavitt [États-Unis] ; Hedy Teppler [États-Unis] | Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies |
| 000273 (2017) |
Tsidiso G. Maphanga [Afrique du Sud] ; Erika Britz [Afrique du Sud] ; Thokozile G. Zulu [Afrique du Sud] ; Ruth S. Mpembe [Afrique du Sud] ; Serisha D. Naicker [Afrique du Sud] ; Ilan S. Schwartz [Belgique] ; Nelesh P. Govender [Afrique du Sud] | In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients. |
| 000287 (2017) |
Melissa H. Watt [États-Unis] ; Alexis C. Dennis [États-Unis] ; Karmel W. Choi [États-Unis] ; Nonceba Ciya [Afrique du Sud] ; John A. Joska [Afrique du Sud] ; Corne Robertson [Afrique du Sud] ; Kathleen J. Sikkema [États-Unis] | Impact of Sexual Trauma on HIV Care Engagement: Perspectives of Female Patients with Trauma Histories in Cape Town, South Africa. |
| 000290 (2017) |
Pablo F. Belaunzarán-Zamudio [Mexique] ; Livio Azzoni [États-Unis] ; David H. Canaday [États-Unis] ; Yanink N. Caro-Vega [Mexique] ; Brian Clagget [États-Unis] ; Mohammed S. Rassool [Afrique du Sud] ; Benigno Rodriguez [États-Unis] ; Ian Sanne [Afrique du Sud] ; Irini Sereti [États-Unis] ; Juan G. Sierra-Madero [Mexique] ; Michael M. Lederman [États-Unis] | Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial. |
| 000295 (2017) |
Anushka Naidoo ; Kogieleum Naidoo ; Veron Ramsuran [Afrique du Sud] ; Millidhashni Reddy ; Nesri Padayatchi | Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele. |
| 000300 (2017) |
Diana Huis In T Veld [Belgique] ; Supa Pengpid [Thaïlande] ; Robert Colebunders [Belgique] ; Linda Skaal [Afrique du Sud] ; Karl Peltzer [Thaïlande] | High-risk alcohol use and associated socio-demographic, health and psychosocial factors in patients with HIV infection in three primary health care clinics in South Africa. |
| 000307 (2017) |
Elizabeth M. Etta [Afrique du Sud] ; Lufuno Mavhandu [Afrique du Sud] ; Cecile Manhaeve [Afrique du Sud] ; Keanan Mcgonigle [États-Unis] ; Patrick Jackson [États-Unis] ; David Rekosh [Afrique du Sud] ; Marie-Louise Hammarskjold [Afrique du Sud] ; Pascal O. Bessong [Afrique du Sud] ; Denis M. Tebit [Afrique du Sud] | High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa. |
